Bortezomib is used for treating relapsed multiple myeloma and mantle cell lymphoma.
Bortezomib interferes with the growth of cancer cells, which are then eventually destroyed by the body. Since the growth of normal body cells may also be affected by bortezomib, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, such as a skin rash, may not be serious but may cause concern. Some effects may not occur until months or years after the medicine is used.
- Product: Bortezomib
- CAS NO.: 179324-69-7
- M.F.: C19H25BN4O4
- M.W.: 384.2372
- Appearance: white or almost white powder
- Usage: to treat multiple myeloma
|Packaging details: ||25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum. |
|Storage: ||Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat |
|Shelf Life: ||5 years if sealed and store away from direct sun light. |